Related Experiment Video
Updated: Jun 12, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Hyperfertility, obesity, and stillbirth: new considerations for clinical practice
Louis G Keith1, Tawanda Ngorima, Olha M Tsar
1Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University; Chicago, Illinois USA.
Summary
This study examines hyperfertility and obesity, two significant global health issues impacting women's reproductive health. Understanding their connection is crucial for effective clinical management by healthcare providers.
Area of Science:
- Reproductive Medicine
- Public Health
- Endocrinology
Background:
- Hyperfertility and obesity are prevalent global health concerns.
- Both conditions significantly impact women of reproductive age.
- Recent evidence highlights the growing importance of these issues.
Purpose of the Study:
- To explore the interplay between hyperfertility and obesity.
- To identify the clinical challenges posed by these interconnected conditions.
- To provide an evidence-based overview for physicians.
Main Methods:
- Review of recently published scientific evidence.
- Analysis of the relationship between hyperfertility and obesity.
- Synthesis of clinical implications for healthcare providers.
Main Results:
- Hyperfertility and obesity frequently coexist in women of reproductive age.
- The combination of these conditions presents unique diagnostic and management challenges.
- Evidence suggests a complex interaction influencing reproductive outcomes.
Conclusions:
- Hyperfertility and obesity represent a substantial clinical challenge in obstetrics and gynecology.
- Physicians require updated knowledge to effectively manage these intertwined conditions.
- Further research is warranted to elucidate the mechanisms and optimize treatment strategies.
More Related Videos
Related Concept Videos
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:28Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...